NHS Framework Agreement, Branded Medicines for London and South of England

NHS EnglandcontractContracts Finder ↗Ref CF-0345200D0O000000rwimUAA2SME suitablecomplete

Estimated value

£442.0m

Awarded value

£558.5m

Awarded 18 Aug 2021

Suppliers

1

Lots

1

1 awarded

Published

17 Sept 2021

Deadline 04 Jun 2021

Awarded suppliers· 1 supplier

Awarded 18 Aug 2021 · Contract period 31 Aug 2021 — 30 Aug 2023

Award value

£558.5m

1

DL

Dr.Reddy's Laboratories (UK) Limited,Accord-UK Ltd,Techdow Pharma England Ltd,UL Global Pharma,Biogen,Amgen Ltd,Thornton and Ross Ltd,Merck Sharpe & Dohme (UK) Limited,Bayer Ltd,Zentiva Pharma UK Ltd,Napp Pharmaceuticals Ltd,Novo Nordisk,Daiichi Sankyo UK Ltd,Gedeon Richter UK Ltd,Teva UK Limited,Pfizer Ltd,Roche Products Ltd,Janssen-Cilag Ltd,Mylan,Allergan,Organon Pharmaceuticals UK Ltd,Sandoz Ltd,Celltrion Healthcare United Kingdom Limited,Sobi (Swedish Orphan Biovitrum Ltd),Merck Serono Limited,Bristol Myers Squibb,Eli Lilly & Company Ltd,Vifor Pharma UK Ltd,Merz,Takeda UK Ltd,AstraZeneca,Ferring Pharmaceuticals Ltd,Aventis Pharma ltd t/a Sanofi,Pharmacosmos UK Ltd,Tetris Pharma Lts,Ipsen,Profile Pharma Ltd,CST Pharma Limited,Gilead Sciences Limited,Morningside Pharmaeuticals,Chugai,UCB